Robert Lanza, Chief Scientific Officer at ADVANCED CELL TECHNOLOGY, INC. (ACTC), sold 2,000,000 shares at $0.15 ($275K) on 2010-12-07, disclosed to the SEC on 2010-12-08.
Open-market sale of $275k ACTC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.13 | 1,271,864 | $165K | 60.2% |
| 2 | $0.15 | 728,136 | $109K | 39.8% |
| Total | $0.14 avg | 2,000,000 | $275K | 100% |
| Filing → |
| ACTC | SELL | 2012-12-18 | $80K | — | Filing → |
| ACTC | SELL | 2012-08-01 | $160K | — | Filing → |
| ACTC | SELL | 2012-01-25 | $1.4M | — | Filing → |